Picton Mahoney Asset Management’s Moderna MRNA Stock Holding History

Picton Mahoney Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-23,436	Closed	-$2.85M	–	457
2023 Q2	$2.85M	Buy	23,436 +4,202	+22%	+$561K	0.12%	193
2023 Q1	$2.96M	Sell	19,234 -3,751	-16%	-$619K	0.13%	201
2022 Q4	$4.13M	Buy	+22,985	New	+$3.76M	0.19%	143
2021 Q3	–	Sell	-9,921	Closed	-$2.33M	–	928
2021 Q2	$2.33M	Buy	+9,921	New	+$1.77M	0.07%	285

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Picton Mahoney Asset Management's MRNA Position: Q3 2023 in Review

Picton Mahoney Asset Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 23,436 shares — an estimated $2.85M sold.

Picton Mahoney Asset Management first reported a position in MRNA in Q2 2021 and held it in 4 quarters. The position peaked at $4.13M in Q4 2022. 890 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

Picton Mahoney Asset Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
Picton Mahoney Asset Management sold 23,436 Moderna shares in Q3 2023, an estimated $2.85M.
Picton Mahoney Asset Management first reported a position in Moderna in Q2 2021 and held it in 4 quarters.
Picton Mahoney Asset Management's Moderna position peaked at $4.13M in Q4 2022.
890 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2023, filed 6 Nov 2023.